학술논문
Long-term benefit of empagliflozin on life expectancy in patients with type 2 diabetes mellitus and established cardiovascular disease survival estimates from the Empa-Reg OUTCOME trial
Document Type
Article
Author
Source
In: Circulation . (Circulation, 2018, 138(15):1599-1601)
Subject
Language
English
ISSN
15244539
00097322
00097322